Insights into the regulation of the matriptase-prostasin proteolytic system. Issue 22 (27th November 2020)

• Record Type: Journal Article
• Authors: Holt-Danborg, Lasse; Skovbjerg, Signe; Goderum, Kristian W.; Nonboe, Annika W.; Stankevic, Evelina; Frost, Ásdis K.; Vitved, Lars; Jensen, Jan K.; Vogel, Lotte K.
• Is Part Of: Biochemical journal. Volume 477:Issue 22(2020)
• Page Start: 4349
• Page End: 4365
• Publication Date: 2020-11-27
• Subjects: HAI-1 -- HAI-2 -- matriptase -- prostasin -- serine proteases -- zymogen activity; Biochemistry -- Periodicals; 572
• DOI: 10.1042/BCJ20200630
• Languages: English
• ISSNs: 0264-6021

Abstract

Abstract : The membrane-associated prostasin and matriptase belonging to the S1A subfamily of serine proteases, are critical for epithelial development and maintenance. The two proteases are involved in the activation of each other and are both regulated by the protease inhibitors, HAI-1 and HAI-2. The S1A subfamily of serine proteases are generally produced as inactive zymogens requiring a cleavage event to obtain activity. However, contrary to the common case, the zymogen form of matriptase exhibits proteolytic activity, which can be inhibited by HAI-1 and HAI-2, as for the activated counterpart. We provide strong evidence that also prostasin exhibits proteolytic activity in its zymogen form. Furthermore, we show that the activity of zymogen prostasin can be inhibited by HAI-1 and HAI-2. We report that zymogen prostasin is capable of activating zymogen matriptase, but unable to activate its own zymogen form. We propose the existence of an unusual enzyme–enzyme relationship consisting of proteolytically active zymogen forms of both matriptase and prostasin, kept under control by HAI-1 and HAI-2, and located at the pinnacle of an important proteolytic pathway in epithelia. Perturbed balance in this proteolytic system is likely to cause rapid and efficient activation of matriptase by the dual action of zymogen matriptase and zymogen prostasin. Previous studies suggest that the zymogen form of matriptase performs the normal proteolytic functions of the protease, whereas excess matriptase activation likely causes carcinogenesis. HAI-1 and HAI-2 are thus important for the prevention of matriptase activation whether catalysed by zymogen/activated prostasin (this study) or zymogen/activated matriptase (previous studies).